Adjuvant interferon in high-risk melanoma: The AIM HIGH study - United Kingdom Coordinating Committee on cancer research randomized study of adjuvant low-dose extended-duration interferon alfa-2a in high-risk resected malignant melanoma

B. W. Hancock, K. Wheatley, S. Harris, N. Ives, G. Harrison, J. M. Horsman, M. R. Middleton, N. Thatcher, P. C. Lorigan, J. R. Marsden, L. Burrows, M. Gore

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Adjuvant interferon in high-risk melanoma: The AIM HIGH study - United Kingdom Coordinating Committee on cancer research randomized study of adjuvant low-dose extended-duration interferon alfa-2a in high-risk resected malignant melanoma'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Agricultural and Biological Sciences

    Nursing and Health Professions

    Neuroscience